Corcept Therapeutics Incorporated (CORT) vs Madrigal Pharmaceuticals, Inc. (MDGL)
Corcept Therapeutics Incorporated and Madrigal Pharmaceuticals, Inc. are both Biotechnology companies. Corcept Therapeutics Incorporated and Madrigal Pharmaceuticals, Inc. are of similar size ($12.9B and $11.9B). Madrigal Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Corcept Therapeutics Incorporated trades at 223×. Madrigal Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 149.0% against 16.0%. Corcept Therapeutics Incorporated has the higher net margin (6.53% vs −25.3%) and the higher return on invested capital (1.01% vs −787.3%). Across the 18 metrics below, Corcept Therapeutics Incorporated leads on 12 and Madrigal Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | CORT | MDGL | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.30% | 91.48% | 65.16% |
| Operating margin | 0.77% | (25.13%) | 0.00% |
| Net margin | 6.53% | (25.32%) | 0.00% |
| Free cash flow margin | 12.87% | (16.07%) | 0.00% |
| Return on equity | 8.08% | (53.31%) | (57.72%) |
| Return on assets | 6.41% | (28.77%) | (49.22%) |
| Return on invested capital | 1.01% | (787.33%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack